METROPOLITAN LIFE INSURANCE CO/NY - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$158,721
-22.1%
5,907
+3.5%
0.01%
-20.0%
Q2 2023$203,619
+40.4%
5,7100.0%0.01%
+42.9%
Q1 2023$145,034
-43.8%
5,710
-10.2%
0.01%
-41.7%
Q4 2022$257,840
+22.7%
6,3570.0%0.01%
+20.0%
Q3 2022$210,099
-6.1%
6,3570.0%0.01%0.0%
Q2 2022$223,830
-23.4%
6,3570.0%0.01%0.0%
Q1 2022$292,358
-89.6%
6,357
-85.0%
0.01%
-73.7%
Q4 2021$2,811,584
+3.5%
42,407
-2.5%
0.04%
-2.6%
Q3 2021$2,715,705
-27.1%
43,500
-3.3%
0.04%
-25.0%
Q2 2021$3,723,836
+26.9%
44,963
+1.6%
0.05%
+18.2%
Q1 2021$2,935,411
-13.3%
44,268
+0.4%
0.04%
-13.7%
Q4 2020$3,383,946
+72.8%
44,102
-3.0%
0.05%
+50.0%
Q3 2020$1,958,670
-4.9%
45,487
-4.6%
0.03%
-8.1%
Q2 2020$2,059,817
+31.9%
47,692
-12.1%
0.04%
+12.1%
Q1 2020$1,561,175
-54.6%
54,264
+0.2%
0.03%
-42.1%
Q4 2019$3,436,511
+301.6%
54,178
+78.4%
0.06%
+280.0%
Q3 2019$855,798
+10.5%
30,369
+4.0%
0.02%
+15.4%
Q2 2019$774,197
+45.9%
29,215
+1.0%
0.01%
+30.0%
Q1 2019$530,810
+47.7%
28,9270.0%0.01%
+42.9%
Q4 2018$359,273
-35.2%
28,9270.0%0.01%
-30.0%
Q3 2018$554,531
-99.9%
28,9270.0%0.01%
+66.7%
Q2 2018$393,407,000
+145606.3%
28,927
-21.2%
0.01%
+200.0%
Q3 2016$270,000
+26.2%
36,692
-9.0%
0.00%0.0%
Q2 2016$214,00040,3020.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders